Lena Biosciences, Inc.

Lena Biosciences, Inc. was established in 2008 with a goal of improving cell culture techniques by providing a more physiologically relevant method to predict human outcomes. In 2010, our SeedEZ 3D cell culturing scaffold was conceived allowing cells to grow in three dimensions the way they grow in living tissues. In 2016, our Perfused Organ Panel microphysiological system was born, combining tissue-like 3D cell cultures with perfusion using our proprietary hemoglobin analog, Blood Substitute. This biomimetic cell culturing method enriches oxygen supply to cells and mimics in vivo pericellular perfusion providing an advanced framework to study pharmacodynamics and cell interactions in vitro.